Mackenzie Financial
FBIO icon

Mackenzie Financial’s Fortress Biotech FBIO Stock Holding History

Mackenzie Financial’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.7M Buy
+555,676
New +$1.43M ﹤0.01% 1087

Other funds holding FBIO

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Mackenzie Financial's FBIO Position: Q2 2026 in Review

Mackenzie Financial opened a new position in Fortress Biotech (FBIO) in Q2 2026: 555,676 shares worth $1.7M. The stake represents ﹤0.01% of the portfolio and ranks #1087 among its holdings.

38 funds tracked by Wall St. Rank hold FBIO as of Q2 2026.

  • Mackenzie Financial held 555,676 shares of Fortress Biotech worth $1.7M as of Q2 2026.
  • Fortress Biotech was a new Mackenzie Financial position in Q2 2026.
  • Fortress Biotech made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #1087 holding.
  • 38 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.